Heart rate-lowering and -regulating effects of once-daily sustained-release diltiazem

Clinical Cardiology

Volumn 24, Issue 1, 2001, Pages 73-79

  Boden, William E ^a   Vray, Muriel ^b   Eschwege, Evelyne ^b   Lauret, Delphine ^c   Scheldewaert, Rudy ^c  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b INSERM   (France)

^c SANOFI   (France)

Author keywords

Heart rate; Heart rate lowering calcium channel blockers; Hypertension; Once daily sustained release diltiazem

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PROGNOSIS; SUSTAINED RELEASE PREPARATION; TACHYCARDIA;

ANGINA PECTORIS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; META-ANALYSIS; MIDDLE AGED;

EID: 0035159810     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960240112     Document Type: Article

References (37)

1. Influence of heart rate on mortality among persons with hypertension: The Framingham Study
2. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study
3. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction
4. Influence of heart rate on mortality after acute myocardial infarction
5. Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at rest
6. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: Insights from the GISSI-2 study
7. Effect of verapamil on mortality and major events after acute myocardial infarction
8. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial
9. The effect of diltiazem on mortality and reinfarction after myocardial infarction
10. Beneficial effect of heart rate-lowering calcium channel blockers (diltiazem, verapamil) on reducing long-term (12-18 month) cardiac death and nonfatal reinfarction in patients recovering from acute non-Q-wave myocardial infarction
11. Early administration of nifedipine in suspected acute myocardial infarction: The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 study
12. Early treatment of unstable angina in the coronary care unit: A randomized, double-blind, placebo-controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both
13. Comparative haemodynamic dose-response effects of five slow calcium-channel-blocking agents in coronary artery disease
14. Safety of nifedipine in angina pectoris
15. Tolérance et efficacité du diltiazem LP 300 mg évaluées pendant 6 mois chez 1,172 patients hypertendues
16. Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion
17. Méta-analyse des essais cliniques
18. Twenty-four hour efficacy of two dose levels of a once-daily sustained-released diltiazem formulation in stable angina: A placebo-controlled trial
19. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: A placebo-controlled trial
20. Twenty-four hour efficacy of two dose levels of a once-daily sustained-release diltiazem formulation in stable angina: A placebo-controlled trial
21. Adjusted p values for simultaneous reference
22. Sustained release diltiazem versus metoprolol in stable angina pectoris
23. Diltiazem in comparison with metoprolol in stable angina pectoris
24. Role of calcium antagonists in the treatment of essential hypertension
25. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: Effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment
26. Etude comparative des effects du diltiazem, de la nifédipine et de leur association dans l'angor stable d'effort
27. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham study
28. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm
29. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies
30. The influence of heart rate on coronary artery atherosclerosis
31. Experimental atherosclerosis at the carotid bifurcation of the cynomolgus monkey. Localization, compensatory enlargement and the sparing effect of lowered heart rate
32. Heart rate and cardiovascular risk
33. Calcium channel antagonist: Friend or foe in post-infarction patients?
34. What, if anything, is controversial about calcium antagonists?
35. The NORDIL DILTIAZEM study (Nordil). A prospective intervention trial of calcium antagonist therapy in hypertension
36. Design of a placebo-controlled clinical trial of long-acting diltiazem aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infraction
37. Diltazem in acute myocardial infarction treated with thrombolytic agents: A randomised placebo-controlled trial